An intermediate in pyrimidine biosynthesis
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Ureidosuccinic Acid

Item No. 34126

Technical Information
Formal Name
N-(aminocarbonyl)-aspartic acid
CAS Number
923-37-5
Synonyms
  • N-Carbamoylaspartic Acid
  • N-Carbamoyl-DL-Aspartic Acid
  • NSC 120033
Molecular Formula
C5H8N2O5
Formula Weight
Purity
≥95%
A solid
DMF: 1 mg/mlDMSO: 1 mg/mlPBS (pH 7.2): 1 mg/ml
SMILES
O=C(NC(CC(O)=O)C(O)=O)NO=C(NC(CC(O)=O)C(O)=O)N
InChi Code
InChI=1S/C5H8N2O5/c6-5(12)7-2(4(10)11)1-3(8)9/h2H,1H2,(H,8,9)(H,10,11)(H3,6,7,12)
InChi Key
HLKXYZVTANABHZ-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Ureidosuccinic acid is an intermediate in the de novo pyrimidine nucleotide biosynthesis pathway.1,2 It is formed from aspartate and carbamoyl phosphate via aspartate carbamoyltransferase.1 Ureidosuccinic acid (350 mg/kg) inhibits antitumor activity and toxicity induced by the aspartate carbamoyltransferase inhibitor N-phosphonacetyl-L-aspartate (PALA) in a murine Lewis lung carcinoma model.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Lowenstein, J.M., and Cohen, P.P. Studies on the biosynthesis of carbamylaspartic acid. The Journal of Biological Chemisty 220(1), 57-70 (1956).

    2. Anderson, E.P., Yen, C.Y., Mandel, H.G., et alUreidosuccinic acid as a precursor of nucleic acid pyrimidines in normal and tumor-bearing mice. The Journal of Biological Chemisty 213(2), 625-633 (1955).

    3. Johnson, R.K. Reversal of toxicity and antitumor activity of N-(phosphonacetyl)-L-aspartate by uridine or carbamyl-DL-aspartate in vivo. Biochem. Pharmacol. 26(1), 81-84 (1977).